Xphyto Therapeutics partner Bunker signs agreement with University of Munich
Xphyto Therapeutics (CSE: XPHY) VP European Corporate Development and Managing Director at Bunker, Robert Barth joined Steve Darling on Skype from Germany with news the company has signed an agreement with the University of Munich and their Department of Bio-Chemistry.
Barth talks about what research they will do together and also when their facility “The Bunker” will be up and running.
Barth talks about what research they will do together and also when their facility “The Bunker” will be up and running.
People In This Video
No users are tagged in this video